Da der derfor ikke kan gives doseringsanbefa - linger for kombinationen af Agenerase oral opløsning og lave doser af retronavir skal kombinationen undgås til denne patientgruppe.
Additionally, as no dosing recommendations can be made regarding the concomitant use of Agenerase oral solution and low dose ritonavir, the use of this combination must be avoided in these patient populations.